Schneider M - Search Results

1

Molecular and functional ultrasound imaging in differently aggressive breast cancer xenografts using two novel ultrasound contrast agents (BR55 and BR38).

Bzyl J, Lederle W, Rix A, Grouls C, Tardy I, Pochon S, Siepmann M, Penzkofer T, Schneider M, Kiessling F, Palmowski M. Bzyl J, et al. Among authors: schneider m. Eur Radiol. 2011 Sep;21(9):1988-95. doi: 10.1007/s00330-011-2138-y. Epub 2011 May 12. Eur Radiol. 2011. PMID: 21562807

2

BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis.

Pochon S, Tardy I, Bussat P, Bettinger T, Brochot J, von Wronski M, Passantino L, Schneider M. Pochon S, et al. Among authors: schneider m. Invest Radiol. 2010 Feb;45(2):89-95. doi: 10.1097/RLI.0b013e3181c5927c. Invest Radiol. 2010. PMID: 20027118

3

Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55.

Tardy I, Pochon S, Theraulaz M, Emmel P, Passantino L, Tranquart F, Schneider M. Tardy I, et al. Among authors: schneider m. Invest Radiol. 2010 Oct;45(10):573-8. doi: 10.1097/RLI.0b013e3181ee8b83. Invest Radiol. 2010. PMID: 20808233

4

Ultrasound molecular imaging contrast agent binding to both E- and P-selectin in different species.

Bettinger T, Bussat P, Tardy I, Pochon S, Hyvelin JM, Emmel P, Henrioud S, Biolluz N, Willmann JK, Schneider M, Tranquart F. Bettinger T, et al. Among authors: schneider m. Invest Radiol. 2012 Sep;47(9):516-23. doi: 10.1097/RLI.0b013e31825cc605. Invest Radiol. 2012. PMID: 22814589

5

BR38, a new ultrasound blood pool agent.

Schneider M, Anantharam B, Arditi M, Bokor D, Broillet A, Bussat P, Fouillet X, Frinking P, Tardy I, Terrettaz J, Senior R, Tranquart F. Schneider M, et al. Invest Radiol. 2011 Aug;46(8):486-94. doi: 10.1097/RLI.0b013e318217b821. Invest Radiol. 2011. PMID: 21487303 Clinical Trial.

6

In vivo ultrasound imaging of thrombi using a target-specific contrast agent.

Tardy I, Pochon S, Theraulaz M, Nanjappan P, Schneider M. Tardy I, et al. Among authors: schneider m. Acad Radiol. 2002 Aug;9 Suppl 2:S294-6. doi: 10.1016/s1076-6332(03)80207-6. Acad Radiol. 2002. PMID: 12188252 No abstract available.

7

Use of intravital microscopy to study the microvascular behavior of microbubble-based ultrasound contrast agents.

Schneider M, Broillet A, Tardy I, Pochon S, Bussat P, Bettinger T, Helbert A, Costa M, Tranquart F. Schneider M, et al. Microcirculation. 2012 Apr;19(3):245-59. doi: 10.1111/j.1549-8719.2011.00152.x. Microcirculation. 2012. PMID: 22211713

8

Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55).

Pysz MA, Foygel K, Rosenberg J, Gambhir SS, Schneider M, Willmann JK. Pysz MA, et al. Among authors: schneider m. Radiology. 2010 Aug;256(2):519-27. doi: 10.1148/radiol.10091858. Epub 2010 Jun 1. Radiology. 2010. PMID: 20515975 Free PMC article.

9

Molecular imaging of human thrombus with novel abciximab immunobubbles and ultrasound.

Alonso A, Della Martina A, Stroick M, Fatar M, Griebe M, Pochon S, Schneider M, Hennerici M, Allémann E, Meairs S. Alonso A, et al. Among authors: schneider m. Stroke. 2007 May;38(5):1508-14. doi: 10.1161/STROKEAHA.106.471391. Epub 2007 Mar 22. Stroke. 2007. PMID: 17379828

10

A phospholipid-PEG2000 conjugate of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeting heterodimer peptide for contrast-enhanced ultrasound imaging of angiogenesis.

Pillai R, Marinelli ER, Fan H, Nanjappan P, Song B, von Wronski MA, Cherkaoui S, Tardy I, Pochon S, Schneider M, Nunn AD, Swenson RE. Pillai R, et al. Among authors: schneider m. Bioconjug Chem. 2010 Mar 17;21(3):556-62. doi: 10.1021/bc9005688. Epub 2010 Feb 19. Bioconjug Chem. 2010. PMID: 20170116

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,263 results

Search Page